ALLEGRO MICROSYSTEMS, INC.
For the period ended Sep 25, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 25, 2026 · Filed Oct 30, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-26; filed 2026-07-31.
0001193125-26-327128
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2026-09-25; filed 2026-10-30.
0001193125-26-439990
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 7 current paragraphs.
6 unchanged; 0 reworded; 1 added; 4 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
During the three-month period ended September 25, 2026, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408 of Regulation S-K.
Removed paragraphs (4)
Previous report
On May 11, 2026, Erin Hagen, the Company’s Senior Vice President, Chief Human Resources Officer, adopted a trading arrangement for the sale of shares of the Company’s common stock that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “Rule 10b5-1 Trading Plan”). Ms. Hagen's Rule 10b5-1 Trading Plan, which terminates at the close of trading on October 25, 2027, for a total duration of 532 days, provides for the potential sale of up to 6,250 shares of the Company’s common stock pursuant to the terms of the plan. The actual number of shares sold under the Rule 10b5-1 Trading Plan will depend on the sale price of the shares and the resulting amount of gross proceeds.
Previous report
On May 20, 2026, Jennie Raubacher, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 Trading Plan. Ms. Raubacher’s Rule 10b5-1 Trading Plan, which terminates at the close of trading on March 31, 2027, for a total duration of 315 days, provides for the sale of up to 4,000 shares of the Company’s common stock pursuant to the terms of the plan.
Previous report
On May 26, 2026, Sharon Briansky, the Company’s Senior Vice President, General Counsel and Corporate Secretary, adopted a Rule 10b5-1 Trading Plan. The Rule 10b5-1 Trading Plan, which terminates at the close of trading on May 3, 2027, for a total duration of 342 days, provides for the potential sale of up to 19,895 shares of the Company’s common stock pursuant to the terms of the plan.
Previous report
On June 11, 2026, the Michael Doogue Revocable Trust of 2015, which Michael Doogue, the Company's Chief Executive Officer, serves as trustee and as the trust’s indirect beneficial owner, adopted a Rule 10b5-1 Trading Plan. The Rule 10b5-1 Trading Plan, which terminates at the close of trading on June 11, 2028, for a total duration of 731 days, provides for the sale of up to 75,000 shares of the Company’s common stock pursuant to the terms of the plan.